Cargando…
Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign
OBJECTIVES: A strong COVID-19 vaccine campaign is needed to reach the herd immunity and reduce this pandemic infection. STUDY DESIGN: In the Foch Hospital, France, in February 2021, 451 healthcare workers were vaccinated by a first dose of AstraZeneca vaccine. METHODS: Adverse effects were reported...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society for Public Health. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169320/ https://www.ncbi.nlm.nih.gov/pubmed/34198072 http://dx.doi.org/10.1016/j.puhe.2021.05.030 |
_version_ | 1783702034651807744 |
---|---|
author | Vallée, A. Chan-Hew-Wai, A. Bonan, B. Lesprit, P. Parquin, F. Catherinot, É. Choucair, J. Billard, D. Amiel-Taieb, C. Camps, È. Cerf, C. Zucman, D. Fourn, E. |
author_facet | Vallée, A. Chan-Hew-Wai, A. Bonan, B. Lesprit, P. Parquin, F. Catherinot, É. Choucair, J. Billard, D. Amiel-Taieb, C. Camps, È. Cerf, C. Zucman, D. Fourn, E. |
author_sort | Vallée, A. |
collection | PubMed |
description | OBJECTIVES: A strong COVID-19 vaccine campaign is needed to reach the herd immunity and reduce this pandemic infection. STUDY DESIGN: In the Foch Hospital, France, in February 2021, 451 healthcare workers were vaccinated by a first dose of AstraZeneca vaccine. METHODS: Adverse effects were reported to our pharmaco-vigilance circuit, by an online and anonymous questionnaire following the first weeks of the vaccinal campaign to healthcare workers. RESULTS: Two hundred seventy-four (60.8%) of them reported multiple adverse effects. Main adverse effects reported were feverish state/chills (65.7%), fatigue/physical discomfort (62.4%), arthralgia/muscle pain (61.0%) and fever (44.5%). CONCLUSIONS: On March 2021 many European countries suspended AstraZeneca vaccine for one week due to safety uncertainty. Thus, confidence in its efficacy is undermined. However, the benefit/risk balance is clearly in favor of vaccination. |
format | Online Article Text |
id | pubmed-8169320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Royal Society for Public Health. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81693202021-06-02 Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign Vallée, A. Chan-Hew-Wai, A. Bonan, B. Lesprit, P. Parquin, F. Catherinot, É. Choucair, J. Billard, D. Amiel-Taieb, C. Camps, È. Cerf, C. Zucman, D. Fourn, E. Public Health Short Communication OBJECTIVES: A strong COVID-19 vaccine campaign is needed to reach the herd immunity and reduce this pandemic infection. STUDY DESIGN: In the Foch Hospital, France, in February 2021, 451 healthcare workers were vaccinated by a first dose of AstraZeneca vaccine. METHODS: Adverse effects were reported to our pharmaco-vigilance circuit, by an online and anonymous questionnaire following the first weeks of the vaccinal campaign to healthcare workers. RESULTS: Two hundred seventy-four (60.8%) of them reported multiple adverse effects. Main adverse effects reported were feverish state/chills (65.7%), fatigue/physical discomfort (62.4%), arthralgia/muscle pain (61.0%) and fever (44.5%). CONCLUSIONS: On March 2021 many European countries suspended AstraZeneca vaccine for one week due to safety uncertainty. Thus, confidence in its efficacy is undermined. However, the benefit/risk balance is clearly in favor of vaccination. The Royal Society for Public Health. Published by Elsevier Ltd. 2021-07 2021-06-02 /pmc/articles/PMC8169320/ /pubmed/34198072 http://dx.doi.org/10.1016/j.puhe.2021.05.030 Text en © 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Vallée, A. Chan-Hew-Wai, A. Bonan, B. Lesprit, P. Parquin, F. Catherinot, É. Choucair, J. Billard, D. Amiel-Taieb, C. Camps, È. Cerf, C. Zucman, D. Fourn, E. Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign |
title | Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign |
title_full | Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign |
title_fullStr | Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign |
title_full_unstemmed | Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign |
title_short | Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign |
title_sort | oxford–astrazeneca covid-19 vaccine: need of a reasoned and effective vaccine campaign |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169320/ https://www.ncbi.nlm.nih.gov/pubmed/34198072 http://dx.doi.org/10.1016/j.puhe.2021.05.030 |
work_keys_str_mv | AT valleea oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT chanhewwaia oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT bonanb oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT lespritp oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT parquinf oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT catherinote oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT choucairj oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT billardd oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT amieltaiebc oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT campse oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT cerfc oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT zucmand oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign AT fourne oxfordastrazenecacovid19vaccineneedofareasonedandeffectivevaccinecampaign |